Application 089619
- Type
- ANDA
- Sponsor
- QUAD PHARMS
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | ACETAZOLAMIDE SODIUM | ACETAZOLAMIDE SODIUM | Injectable; Injection | EQ 500MG BASE/VIAL | No | No |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Acetazolamide | ACETAZOLAMIDE SODIUM | Sagent Pharmaceuticals | 58093032-8480-4d0f-82be-92e643bdbea4 | 2026-01-09 | Warnings, Adverse reactions | ACETAZOLAMIDE SODIUM |
| Acetazolamide | ACETAZOLAMIDE SODIUM | Mylan Institutional LLC | 521838b0-a10d-495f-a014-f9ff25a6b6f3 | 2025-02-17 | Warnings, Adverse reactions | ACETAZOLAMIDE SODIUM |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.